Soumya Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Soumya Das has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Arwa Z. Al-Riyami
Department of Hematology Sultan Qaboos University Hospital, University Medical City Muscat Oman
3 shared publications - Benjamin Saxon
Department of Haematology/Oncology Women's and Children's Hospital Adelaide Australia
2 shared publications - Cynthia So‐Osman
Department of Transfusion medicine Sanquin Blood Supply Foundation Amsterdam The Netherlands
2 shared publications - Jana Vanden Broeck
Department of Hematology Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB) Brussels Belgium
2 shared publications - Juilee Shalik Charmode
Assistant Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, Mihan Nagpur, 441108 Maharashtra, India
2 shared publications - Naomi Rahimi‐Levene
Adelson Faculty of Medicine Ariel University Ariel Israel
2 shared publications
Latest Publications
- 12 May 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70131
Optimal Timing of Therapeutic Plasma Exchange and Hepatic Encephalopathy Severity as Predictors of Clinical Outcome in Liver Failure: A Retrospective Observational Study
Acute liver failure (ALF) and acute‐on‐chronic liver failure (ACLF) are associated with high mortality, and therapeutic plasma exchange (TPE) is increasingly used as a bridging therapy. This retrospective observational study evaluated outcomes and predictors of response in 22 liver failure patients undergoing TPE. Demographic details, hepatic encephalopathy (HE) grade, timing of TPE initiation, laboratory parameters, and clinical outcomes were analyzed. Clinical improvement was defined as ≥ 1‐grade HE improvement with hemodynamic stabilization and biochemical recovery. The mean age was 22.9 years, with alcohol‐related liver failure and Wilson's disease being the most common indications. Patients with lower HE grades showed significantly better clinical improvement ( p = 0.031). Earlier initiation of TPE (< 10 days) demonstrated a trend toward improved outcomes, although not statistically significant. Significant reductions in bilirubin, INR, ALT, and AST were observed following TPE. However, biochemical improvement did not always correlate with clinical recovery. Early TPE may improve clinical and biochemical recovery and potentially prevent progression to advanced encephalopathy; however, larger prospective studies and randomized controlled trials are needed to establish the optimal timing of TPE and evaluate its prophylactic role in preventing worsening HE.
- 12 May 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70131
Optimal Timing of Therapeutic Plasma Exchange and Hepatic Encephalopathy Severity as Predictors of Clinical Outcome in Liver Failure: A Retrospective Observational Study
Acute liver failure (ALF) and acute‐on‐chronic liver failure (ACLF) are associated with high mortality, and therapeutic plasma exchange (TPE) is increasingly used as a bridging therapy. This retrospective observational study evaluated outcomes and predictors of response in 22 liver failure patients undergoing TPE. Demographic details, hepatic encephalopathy (HE) grade, timing of TPE initiation, laboratory parameters, and clinical outcomes were analyzed. Clinical improvement was defined as ≥ 1‐grade HE improvement with hemodynamic stabilization and biochemical recovery. The mean age was 22.9 years, with alcohol‐related liver failure and Wilson's disease being the most common indications. Patients with lower HE grades showed significantly better clinical improvement ( p = 0.031). Earlier initiation of TPE (< 10 days) demonstrated a trend toward improved outcomes, although not statistically significant. Significant reductions in bilirubin, INR, ALT, and AST were observed following TPE. However, biochemical improvement did not always correlate with clinical recovery. Early TPE may improve clinical and biochemical recovery and potentially prevent progression to advanced encephalopathy; however, larger prospective studies and randomized controlled trials are needed to establish the optimal timing of TPE and evaluate its prophylactic role in preventing worsening HE.
- Open Access
- 22 April 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (3) , 106454
Automated red cell exchange in acute sickle cell crises: Case series and review of the literature
- 22 April 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (3) , 106454
Open AccessAutomated red cell exchange in acute sickle cell crises: Case series and review of the literature
- 10 February 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (6) , 822-827
Transfusion knowledge online: A Wikipedia deep dive
Background and Objectives: Wikipedia has become a widely consulted source for health‐related information, including transfusion medicine, by both healthcare professionals and the general public. However, the accuracy and completeness of transfusion‐related content on this platform remain understudied. So, we aimed to systematically evaluate the current state and quality of transfusion medicine–related content available on Wikipedia. Materials and Methods: The Wikipedia Subgroup of the Clinical Transfusion Working Party of the International Society of Blood Transfusion (ISBT) conducted a cross‐sectional analysis of transfusion medicine–related Wikipedia articles up to 31 December 2024. Articles were identified using the search terms ‘Transfusion’, ‘Blood Components’, ‘Blood Groups’ and related topics. Data extracted and analysed included article metadata, content metrics, visibility indicators and editorial activity. Results: A total of 190 Wikipedia pages related to transfusion medicine were identified, with an additional 14 domain‐specific webpages. The most common categories were blood groups (15.3%), blood components (13.7%) and clinical transfusion medicine (11.6%). Nearly 50% of pages were created between 2006 and 2010. Only 21.6% of pages were classified as complete, while 48.4% remained in the development phase. Conclusion: This study uncovers significant gaps in transfusion medicine content on Wikipedia, with many articles found to be incomplete or poorly maintained. These findings present a clear opportunity for healthcare professionals, particularly members of the ISBT Clinical Transfusion Working Party's Wikipedia Subgroup, to enhance the quality, accuracy and accessibility of transfusion‐related information through coordinated, collaborative editing efforts.
- 10 February 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (6) , 822-827
Transfusion knowledge online: A Wikipedia deep dive
Background and Objectives: Wikipedia has become a widely consulted source for health‐related information, including transfusion medicine, by both healthcare professionals and the general public. However, the accuracy and completeness of transfusion‐related content on this platform remain understudied. So, we aimed to systematically evaluate the current state and quality of transfusion medicine–related content available on Wikipedia. Materials and Methods: The Wikipedia Subgroup of the Clinical Transfusion Working Party of the International Society of Blood Transfusion (ISBT) conducted a cross‐sectional analysis of transfusion medicine–related Wikipedia articles up to 31 December 2024. Articles were identified using the search terms ‘Transfusion’, ‘Blood Components’, ‘Blood Groups’ and related topics. Data extracted and analysed included article metadata, content metrics, visibility indicators and editorial activity. Results: A total of 190 Wikipedia pages related to transfusion medicine were identified, with an additional 14 domain‐specific webpages. The most common categories were blood groups (15.3%), blood components (13.7%) and clinical transfusion medicine (11.6%). Nearly 50% of pages were created between 2006 and 2010. Only 21.6% of pages were classified as complete, while 48.4% remained in the development phase. Conclusion: This study uncovers significant gaps in transfusion medicine content on Wikipedia, with many articles found to be incomplete or poorly maintained. These findings present a clear opportunity for healthcare professionals, particularly members of the ISBT Clinical Transfusion Working Party's Wikipedia Subgroup, to enhance the quality, accuracy and accessibility of transfusion‐related information through coordinated, collaborative editing efforts.
- 28 November 2025
- Published by Wiley in Transfusion Medicine
- Vol. 36 (2) , 121-132
Burden of transfusion‐transmitted infections among patients with thalassaemia and sickle cell anaemia in India: A systematic review and meta‐analysis
Lifelong blood transfusions, crucial for severe cases of thalassaemia and sickle cell disease (SCD), contribute to a high risk of transfusion‐transmitted infections (TTIs). The current systematic review and meta‐analysis determined the prevalence of transfusion‐transmitted infections (TTIs) among patients with thalassaemia and sickle cell anaemia in India. A systematic search was conducted in PubMed, Scopus, ProQuest, EMBASE and Web of Science for articles published up to September 13, 2025. Title abstract screening followed by full‐text review and data extraction was done by two independent reviewers. Risk of bias was assessed for the included studies. Meta‐analysis was conducted to estimate the pooled prevalence of TTIs. The systematic review and meta‐analysis identified 397 unique articles, with 39 selected for full‐text review. After exclusions, 24 studies spanning from 1990 to 2023 were included. All 24 studies included patients with beta thalassaemia, whereas only one study had data on sickle cell anaemia patients, so this review focuses mainly on the prevalence of TTI in patients with beta thalassaemia. The pooled prevalence of Hepatitis C was 22% (95% CI: 14%–30%; I 2 = 96%), Hepatitis B was 8% (95% CI: 2%–16%; I 2 = 96%) and HIV was 4% (95% CI: 2%–7%; I 2 = 77%) in beta‐thalassaemia patients, all showing high heterogeneity. Meta‐regression revealed a statistically significant decline over time in HBV (Beta = −0.0194, p = p = 0.6642) and HIV showed no significant trend (Beta = −0.0001, p = 0.9839). Significant burden of TTIs is present among transfusion‐dependent thalassaemia and sickle cell anaemia patients in India. Strengthening screening protocols, improving vaccination coverage and implementing targeted healthcare interventions are essential to mitigate this preventable risk.
- 28 November 2025
- Published by Wiley in Transfusion Medicine
- Vol. 36 (2) , 121-132
Burden of transfusion‐transmitted infections among patients with thalassaemia and sickle cell anaemia in India: A systematic review and meta‐analysis
Lifelong blood transfusions, crucial for severe cases of thalassaemia and sickle cell disease (SCD), contribute to a high risk of transfusion‐transmitted infections (TTIs). The current systematic review and meta‐analysis determined the prevalence of transfusion‐transmitted infections (TTIs) among patients with thalassaemia and sickle cell anaemia in India. A systematic search was conducted in PubMed, Scopus, ProQuest, EMBASE and Web of Science for articles published up to September 13, 2025. Title abstract screening followed by full‐text review and data extraction was done by two independent reviewers. Risk of bias was assessed for the included studies. Meta‐analysis was conducted to estimate the pooled prevalence of TTIs. The systematic review and meta‐analysis identified 397 unique articles, with 39 selected for full‐text review. After exclusions, 24 studies spanning from 1990 to 2023 were included. All 24 studies included patients with beta thalassaemia, whereas only one study had data on sickle cell anaemia patients, so this review focuses mainly on the prevalence of TTI in patients with beta thalassaemia. The pooled prevalence of Hepatitis C was 22% (95% CI: 14%–30%; I 2 = 96%), Hepatitis B was 8% (95% CI: 2%–16%; I 2 = 96%) and HIV was 4% (95% CI: 2%–7%; I 2 = 77%) in beta‐thalassaemia patients, all showing high heterogeneity. Meta‐regression revealed a statistically significant decline over time in HBV (Beta = −0.0194, p = p = 0.6642) and HIV showed no significant trend (Beta = −0.0001, p = 0.9839). Significant burden of TTIs is present among transfusion‐dependent thalassaemia and sickle cell anaemia patients in India. Strengthening screening protocols, improving vaccination coverage and implementing targeted healthcare interventions are essential to mitigate this preventable risk.
- 20 May 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (8) , 842-850
E‐learning in transfusion medicine: An exploratory qualitative assessment
Background and Objectives: E‐learning programmes are increasingly offered in transfusion medicine (TM) education. The aim of this study was to explore facilitators and barriers to TM e‐learning programmes, including assessment of learning outcomes and measures of effectiveness.Materials and Methods: Participants selected from a prior survey and representing a diverse number of international e‐learning programmes were invited to participate. A mixed methodology was employed, combining a survey and individual semi‐structured one‐on‐one interviews. Interview data were analysed inductively to explore programme development, evaluation, and facilitators and barriers to implementation.Results: Fourteen participants representing 13 institutions participated in the survey and 10 were interviewed. The e‐learning programmes have been in use for a variable duration between 5 and 16 years. Funding sources varied, including government and institutional support. Learner assessment methods varied and encompassed multiple‐choice‐questions (n = 12), direct observation (n = 4) and competency assessment (n = 4). Most regional and national blood collection agencies rely on user feedback and short‐term learning assessments to evaluate their programmes. Only one respondent indicated an attempt to correlate e‐learning with clinical practices. Factors that facilitated programme implementation included support from management and external audits to ensure compliance with regulatory educational and training requirements. Barriers to programme implementation included the allocation of staff time for in‐house development, enforcing compliance, keeping educational content up‐to‐date and gaining access to outcome data for educational providers.Conclusion: There is evidence of considerable diversity in the evaluation of e‐learning programmes. Further work is needed to understand the ultimate impact of TM e‐learning on transfusion practices and patient outcomes.
- 20 May 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (8) , 842-850
E‐learning in transfusion medicine: An exploratory qualitative assessment
Background and Objectives: E‐learning programmes are increasingly offered in transfusion medicine (TM) education. The aim of this study was to explore facilitators and barriers to TM e‐learning programmes, including assessment of learning outcomes and measures of effectiveness.Materials and Methods: Participants selected from a prior survey and representing a diverse number of international e‐learning programmes were invited to participate. A mixed methodology was employed, combining a survey and individual semi‐structured one‐on‐one interviews. Interview data were analysed inductively to explore programme development, evaluation, and facilitators and barriers to implementation.Results: Fourteen participants representing 13 institutions participated in the survey and 10 were interviewed. The e‐learning programmes have been in use for a variable duration between 5 and 16 years. Funding sources varied, including government and institutional support. Learner assessment methods varied and encompassed multiple‐choice‐questions (n = 12), direct observation (n = 4) and competency assessment (n = 4). Most regional and national blood collection agencies rely on user feedback and short‐term learning assessments to evaluate their programmes. Only one respondent indicated an attempt to correlate e‐learning with clinical practices. Factors that facilitated programme implementation included support from management and external audits to ensure compliance with regulatory educational and training requirements. Barriers to programme implementation included the allocation of staff time for in‐house development, enforcing compliance, keeping educational content up‐to‐date and gaining access to outcome data for educational providers.Conclusion: There is evidence of considerable diversity in the evaluation of e‐learning programmes. Further work is needed to understand the ultimate impact of TM e‐learning on transfusion practices and patient outcomes.
- 24 October 2023
- Published by Wiley in Transfusion
- Vol. 63 (12) , 2362-2376
E‐learning in transfusion medicine: A scoping review
- 24 October 2023
- Published by Wiley in Transfusion
- Vol. 63 (12) , 2362-2376
E‐learning in transfusion medicine: A scoping review
- 28 September 2022
- Published by Wiley in Transfusion Medicine
- Vol. 32 (6) , 499-504
E‐learning/online education in transfusion medicine: A cross‐sectional international survey
Objectives: This survey aims to assess the scope of transfusion e‐learning courses in blood establishments and transfusion services internationally.Background: E‐learning/online education is increasingly used in the education of medical professionals. There is limited published data on the use of e‐learning for transfusion medicine.Material and Methods: An International survey was designed and distributed to all members of the International Society of Blood Transfusion to assess utilisation of e‐learning in their institutions. Descriptive statistics were used to summarise the results.Results: A total of 177 respondents participated, 68 of which had e‐learning modules in their institutions. Approximately two‐thirds of the courses were developed in‐house (66%), and 63% are available to learners from outside the host institutions. In one‐third of institutions, these courses were established during the COVID‐19 pandemic, while 15% had used e‐learning courses for more than 10 years.The courses target different audiences and topics ranging from blood donation to hemovigilance. The most common audiences were physicians (71%), laboratory scientists/technologists (69%) and transfusion practitioners (63%). Formal assessment of learning outcomes is used in 70% of the programs.Conclusions: The survey demonstrates the widespread use of e‐learning courses in transfusion education, with a substantial proportion being developed during the COVID‐19 pandemic.
- 28 September 2022
- Published by Wiley in Transfusion Medicine
- Vol. 32 (6) , 499-504
E‐learning/online education in transfusion medicine: A cross‐sectional international survey
Objectives: This survey aims to assess the scope of transfusion e‐learning courses in blood establishments and transfusion services internationally.Background: E‐learning/online education is increasingly used in the education of medical professionals. There is limited published data on the use of e‐learning for transfusion medicine.Material and Methods: An International survey was designed and distributed to all members of the International Society of Blood Transfusion to assess utilisation of e‐learning in their institutions. Descriptive statistics were used to summarise the results.Results: A total of 177 respondents participated, 68 of which had e‐learning modules in their institutions. Approximately two‐thirds of the courses were developed in‐house (66%), and 63% are available to learners from outside the host institutions. In one‐third of institutions, these courses were established during the COVID‐19 pandemic, while 15% had used e‐learning courses for more than 10 years.The courses target different audiences and topics ranging from blood donation to hemovigilance. The most common audiences were physicians (71%), laboratory scientists/technologists (69%) and transfusion practitioners (63%). Formal assessment of learning outcomes is used in 70% of the programs.Conclusions: The survey demonstrates the widespread use of e‐learning courses in transfusion education, with a substantial proportion being developed during the COVID‐19 pandemic.
- 19 July 2021
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 14 (7) , 3716-3720
Hepatoproective Nature of Aerial parts of Caesalpinia pulcherrima in STZ Induced Diabetic Rat Model
- 19 July 2021
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 14 (7) , 3716-3720
Hepatoproective Nature of Aerial parts of Caesalpinia pulcherrima in STZ Induced Diabetic Rat Model
- 1 November 2020
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 27 (4) , 270-272
Recognizing the role of transfusion medicine specialist in the modern era
- 1 November 2020
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 27 (4) , 270-272
Recognizing the role of transfusion medicine specialist in the modern era
- 24 September 2020
- Published by Wiley in Transfusion Medicine
- Vol. 31 (1) , 30-35
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease
Objective: We aimed to assess the frequency distribution of of ABO haemolytic disease of newborn (ABO‐HDN) and to know the predictive value of immunohaematological tests in identifying at risk neonates.Background: ABO incompatibility, although a common cause of haemolytic disease of newborn, has several unaddressed issues related to it.Material and methods: A prospective study over 20 months was carried out in a tertiary care centre in South India. Blood grouping, Direct Antiglobulin test (DAT) and elution studies were performed on neonatal samples, whereas blood grouping, antibody screening and antibody titration were performed on maternal samples. In suspected cases, ABO‐HDN was diagnosed after excluding other possible causes for haemolysis. The laboratory results were correlated with the clinical details to assess the predictive value of the tests.Results: Of the total 2856 pregnancies, 34% had ABO incompatibility. On testing with columnagglutination test (CAT), the overall DAT positivity and that among ABO‐incompatible cases were 3.8% and 11.2%, respectively,) whereas by conventinal tube technique (CTT) it was 0.6% and 2.4% respectively. CAT was found to have higher sensitivity, and the predictive value was higher for CTT. Maternal IgG titre showed a positive linear relationship with the DAT strength and the rise in indirect bilirubin levels. The positive predictive value of combination of tests such as DAT, elution and titation was 94.12%, which was much higher than that of the individual tests.Conclusion: DAT positivity is a predictor of early rise in serum bilirubin level, and a combination of tests has a better predictive value than individual tests towards development of clinically significant hyperbilirubinemia in ABO‐HDN.
- 24 September 2020
- Published by Wiley in Transfusion Medicine
- Vol. 31 (1) , 30-35
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease
Objective: We aimed to assess the frequency distribution of of ABO haemolytic disease of newborn (ABO‐HDN) and to know the predictive value of immunohaematological tests in identifying at risk neonates.Background: ABO incompatibility, although a common cause of haemolytic disease of newborn, has several unaddressed issues related to it.Material and methods: A prospective study over 20 months was carried out in a tertiary care centre in South India. Blood grouping, Direct Antiglobulin test (DAT) and elution studies were performed on neonatal samples, whereas blood grouping, antibody screening and antibody titration were performed on maternal samples. In suspected cases, ABO‐HDN was diagnosed after excluding other possible causes for haemolysis. The laboratory results were correlated with the clinical details to assess the predictive value of the tests.Results: Of the total 2856 pregnancies, 34% had ABO incompatibility. On testing with columnagglutination test (CAT), the overall DAT positivity and that among ABO‐incompatible cases were 3.8% and 11.2%, respectively,) whereas by conventinal tube technique (CTT) it was 0.6% and 2.4% respectively. CAT was found to have higher sensitivity, and the predictive value was higher for CTT. Maternal IgG titre showed a positive linear relationship with the DAT strength and the rise in indirect bilirubin levels. The positive predictive value of combination of tests such as DAT, elution and titation was 94.12%, which was much higher than that of the individual tests.Conclusion: DAT positivity is a predictor of early rise in serum bilirubin level, and a combination of tests has a better predictive value than individual tests towards development of clinically significant hyperbilirubinemia in ABO‐HDN.